Leukemia Research
Volume 25, Issue 9 , Pages 757-767 , 1 September 2001

AC133 antigen as a prognostic factor in acute leukemia

Received 14 July 2000 ,Accepted 28 December 2000.

References 

  1. Miraglia S, Godfrey W, Yin AH, Atkins K, Warnke R, Holden JT, et al. A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood. 1997;90(12):5013–5021
  2. Yin AH, Miraglia S, Zanjani ED, Almeida-Porada G, Ogawa M, Leary AG, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood. 1997;90(12):5002–5012
  3. Snell V, Jackson D, Buck D, Andreeff M. Expression of the AC133 antigen in leukemic and normal progenitors. Blood. 1998;92:119a
  4. Buhring HJ, Seiffert M, Marxer A, Weiss B, Faul C, Kanz L, et al. AC133 antigen expression is not restricted to acute myeloid leukemia blasts but is also found on acute lymphoid leukemia blasts and on a subset of CD34+ B-cell precursors. Blood. 1999;94(2):832–833
  5. Horn PA, Tesch H, Staib P, Kube D, Diehl V, Voliotis D. Expression of AC133, a novel hematopoietic precursor antigen, on acute myeloid leukemia cells. Blood. 1999;93(4):1435–1437
  6. Sperling C, Buchner T, Creutzig U, Ritter J, Harbott J, Fonatsch C, et al. Clinical, morphologic, cytogenetic and prognostic implications of CD34 expression in childhood and adult de novo AML. Leuk. Lymphoma. 1995;17(5-6):417–426
  7. Cacciola E, Guglielmo P, Cacciola E, Stagno F, Cacciola RR, Impera S. CD34 expression in adult acute lymphoblastic leukemia. Leuk. Lymphoma. 1995;18(1):31–36
  8. Thomas X, Archimbaud E, Charrin C, Magaud JP, Fiere D. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia. Leukemia. 1995;9(2):249–253
  9. Dalal BI, Wu V, Barnett MJ, Horsman DE, Spinelli JJ, Naiman SC, et al. Induction failure in de novo acute myelogenous leukemia is associated with expression of high levels of CD34 antigen by the leukemic blasts. Leuk. Lymphoma. 1997;26(3–4):299–306
  10. Raspadori D, Lauria F, Ventura MA, Rondelli D, Visani G, de Vivo A, et al. Incidence and prognostic relevance of CD34 expression in acute myeloblastic leukemia: analysis of 141 cases. Leuk. Res. 1997;21(7):603–607
  11. Fruchart C, Lenormand B, Bastard C, Boulet D, Lesesve JF, Callat MP, et al. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia. Am. J. Hematol. 1996;53(3):175–180
  12. Ogawa M, Kizumoto M, Nishikawa S, Fujimoto T, Kodama H, Nishikawa SI. Expression of alpha4-integrin defines the earliest precursor of hematopoietic cell lineage diverged from endothelial cells. Blood. 1999;93(4):1168–1177
  13. Pierelli L, Scambia G, Fattorossi A, Bonanno G, Battaglia A, Rumi C, et al. Functional, phenotypic and molecular characterization of cytokine low-responding circulating CD34+ haemopoietic progenitors. Br. J. Haematol. 1998;102(5):1139–1150
  14. Campos L, Rouault JP, Sabido O, Oriol P, Roubi N, Vasselon C, et al. High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. Blood. 1993;81(11):3091–3096
  15. Lauria F, Raspadori D, Rondelli D, Ventura MA, Fiacchini M, Visani G, et al. High bcl-2 expression in acute myeloid leukemia cells correlates with CD34 positivity and complete remission rate. Leukemia. 1997;11(12):2075–2078
  16. Bradstock KF, Gottlieb DJ. Interaction of acute leukemia cells with the bone marrow microenvironment: implications for control of minimal residual disease. Leuk. Lymphoma. 1995;18(1–2):1–16
  17. Cacciola RR, Stagno F, Impera S, Assisi AR, Cacciola E, Guglielmo P. Beta-1-integrin expression in adult acute lymphoblastic leukemia: possible relationship with the stem cell antigen CD34. Acta. Haematol. 1997;97(1-2):63–66
  18. Kobayashi M, Imamura M, Uede T, Sakurada K, Maeda S, Iwasaki H, et al. Expression of adhesion molecules on human hematopoietic progenitor cells at different maturational stages. Stem Cells. 1994;12(3):316–321
  19. Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF. Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature. 1987;328(6128):342–344
  20. Reuss-Borst MA, Klein G, Waller HD, Muller CA. Differential expression of adhesion molecules in acute leukemia. Leukemia. 1995;9(5):869–874
  21. Vila L, Thomas X, Campos L, Sabido O, Archimbaud E. Expression of VLA molecules on acute leukemia cells: relationship with disease characteristics. Exp. Hematol. 1995;23(6):514–518
  22. Manabe A, Coustan-Smith E, Behm FG, Raimondi SC, Campana D. Bone marrow-derived stromal cells prevent apoptotic cell death in B-lineage acute lymphoblastic leukemia. Blood. 1992;79(9):2370–2377
  23. Ryan DH, Nuccie BL, Abboud CN, Winslow JM. Vascular cell adhesion molecule-1 and the integrin VLA-4 mediate adhesion of human B cell precursors to cultured bone marrow adherent cells. J. Clin. Invest. 1991;88(3):995–1004
  24. Sudhoff T, Wehmeier A, Kliche KO, Aul C, Schlomer P, Bauser U, et al. Levels of circulating endothelial adhesion molecules (sE-selectin and sVCAM-1) in adult patients with acute leukemia. Leukemia. 1996;10(4):682–686
  25. Möhle R, Bautz F, Rafii S, Moore MA, Brugger W, Kanz L. The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood. 1998;91(12):4523–4530
  26. Aiuti A, Webb IJ, Bleul C, Springer T, Gutierrez-Ramos JC. The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood. J. Exp. Med. 1997;185(1):111–120
  27. Spertini O, Callegari P, Cordey AS, Hauert J, Joggi J, von Fliedner V, et al. High levels of the shed form of l-selectin are present in patients with acute leukemia and inhibit blast cell adhesion to activated endothelium. Blood. 1994;84(4):1249–1256
  28. Young KL, Watts M, Shaun Thomas N, Sullivan A, Ings S, Linch DC. Transmigration of CD34+ cells across specialized and nonspecialized endothelium requires prior activation by growth factors and is mediated by PECAM-1 (CD31). Blood. 1998;91(4):1196–1205
  29. Cavenagh JD, Gordon-Smith EC, Gibson FM, Gordon MY. Acute myeloid leukaemia blast cells bind to human endothelium in vitro utilizing E-selectin and vascular cell adhesion molecule-1 (VCAM-1). Br. J. Haematol. 1993;85(2):285–291

PII: S0145-2126(01)00016-9

Leukemia Research
Volume 25, Issue 9 , Pages 757-767 , 1 September 2001

Article Tools

* Image Usage & Resolution